Media Summary: Dale N. Gerding, MD; Yoav Golan, MD; and Peter Salgo, MD, remark on recent updates to guidelines for the management of ... Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, highlight 4 Your Health: Purdue researchers develop possible

C Difficile A Change In First Line Treatment And New Biologic Agent - Detailed Analysis & Overview

Dale N. Gerding, MD; Yoav Golan, MD; and Peter Salgo, MD, remark on recent updates to guidelines for the management of ... Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, highlight 4 Your Health: Purdue researchers develop possible Dale N Gerding, MD, research physician at Edward Hines Jr. Veterans Administration Hospital, discusses the most recent ... Colleen Kelly, MD, FACG, Brown University shared at the 2015 American College of Gastroenterology Annual Scientific Meeting ... On this episode, we review the 2021 Focused Update Guidelines on Management of Clostridioides

Dr. Mercurio, an ID Clinical Pharmacy Specialist at the James A Haley Veterans Hospital, presents an update on Dr. Contreras, Infectious Diseases fellow at the University of South Florida, discusses a review of Earn CME for related activities: In this webcast from the 'Recognizing, Dr. Sahil Khanna, a Professor of Medicine in Gastroenterology at Mayo Clinic in Rochester, MN, sharing insights from his article ... Learning objective 1. Describe the pharmacokinetic and pharmacodynamic properties of antibiotics used for CDI. Learning ... Nicola Petrosillo, MD, discusses current controversies in

Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, discuss how the costs and benefits of newer ...

Photo Gallery

C difficile: A Change in First-Line Treatment and New Biologic Agent
Guideline Updates in the Management of C. Difficile
Treatment Options for Newly Diagnosed C. Difficile
4 Your Health: Purdue researchers develop possible treatment for C. Diff
IBD School 222 C Difficile Therapy: Vanco, Flagyl, FMT
C. difficile, Diagnosis, Treatment, and Isolation
Exploring the Latest Update to the C difficile Guidelines
Q&A with Colleen Kelly: Treatment Options for C. Difficile Infections
New and Emerging Options for Treating Recurrent C difficile
2021 C. difficile Treatment Guidelines
🦠 A new bacterial treatment for Clostridioides difficile infection (CDI)?
Clostridium Difficile Infection: Old Treatments and New Strategies - Linda Cheung, PharmD
Sponsored
Sponsored
View Detailed Profile
C difficile: A Change in First-Line Treatment and New Biologic Agent

C difficile: A Change in First-Line Treatment and New Biologic Agent

New

Guideline Updates in the Management of C. Difficile

Guideline Updates in the Management of C. Difficile

Dale N. Gerding, MD; Yoav Golan, MD; and Peter Salgo, MD, remark on recent updates to guidelines for the management of ...

Sponsored
Treatment Options for Newly Diagnosed C. Difficile

Treatment Options for Newly Diagnosed C. Difficile

Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, highlight

4 Your Health: Purdue researchers develop possible treatment for C. Diff

4 Your Health: Purdue researchers develop possible treatment for C. Diff

4 Your Health: Purdue researchers develop possible

IBD School 222 C Difficile Therapy: Vanco, Flagyl, FMT

IBD School 222 C Difficile Therapy: Vanco, Flagyl, FMT

Muza-Moons discusses therapies for

Sponsored
C. difficile, Diagnosis, Treatment, and Isolation

C. difficile, Diagnosis, Treatment, and Isolation

MDstewardship Educational Series.

Exploring the Latest Update to the C difficile Guidelines

Exploring the Latest Update to the C difficile Guidelines

Dale N Gerding, MD, research physician at Edward Hines Jr. Veterans Administration Hospital, discusses the most recent ...

Q&A with Colleen Kelly: Treatment Options for C. Difficile Infections

Q&A with Colleen Kelly: Treatment Options for C. Difficile Infections

Colleen Kelly, MD, FACG, Brown University shared at the 2015 American College of Gastroenterology Annual Scientific Meeting ...

New and Emerging Options for Treating Recurrent C difficile

New and Emerging Options for Treating Recurrent C difficile

Paul G. Auwaerter, MD, discusses

2021 C. difficile Treatment Guidelines

2021 C. difficile Treatment Guidelines

On this episode, we review the 2021 Focused Update Guidelines on Management of Clostridioides

🦠 A new bacterial treatment for Clostridioides difficile infection (CDI)?

🦠 A new bacterial treatment for Clostridioides difficile infection (CDI)?

The

Clostridium Difficile Infection: Old Treatments and New Strategies - Linda Cheung, PharmD

Clostridium Difficile Infection: Old Treatments and New Strategies - Linda Cheung, PharmD

Linda Cheung, PharmD, speaks about the

Clostridium Difficile Treatment: Focus on the New Guidelines -- Amanda Mercurio, PharmD.

Clostridium Difficile Treatment: Focus on the New Guidelines -- Amanda Mercurio, PharmD.

Dr. Mercurio, an ID Clinical Pharmacy Specialist at the James A Haley Veterans Hospital, presents an update on

Clostridium difficile: History, Management, And Updates -- Alberto Contreras, MD

Clostridium difficile: History, Management, And Updates -- Alberto Contreras, MD

Dr. Contreras, Infectious Diseases fellow at the University of South Florida, discusses a review of

Case-Based Discussion: Treatment Considerations for IBD Patients With Recurrent C. diff Infections

Case-Based Discussion: Treatment Considerations for IBD Patients With Recurrent C. diff Infections

Earn CME for related activities: https://www.naccme.com/ias In this webcast from the 'Recognizing,

My Treatment Approach to Clostridioides difficile Infection

My Treatment Approach to Clostridioides difficile Infection

Dr. Sahil Khanna, a Professor of Medicine in Gastroenterology at Mayo Clinic in Rochester, MN, sharing insights from his article ...

Clostridioides difficile Infection (C diff)

Clostridioides difficile Infection (C diff)

Learning objective 1. Describe the pharmacokinetic and pharmacodynamic properties of antibiotics used for CDI. Learning ...

Controversies in C Difficile Prevention

Controversies in C Difficile Prevention

Nicola Petrosillo, MD, discusses current controversies in

Cost-Benefit Analysis for C. Difficile Infection Therapies

Cost-Benefit Analysis for C. Difficile Infection Therapies

Dale N. Gerding, MD; Yoav Golan, MD; Darrell S. Pardi, MD; and Peter Salgo, MD, discuss how the costs and benefits of newer ...

Diagnosis and therapy of C.difficile infection -- with mild/moderate and severe disease

Diagnosis and therapy of C.difficile infection -- with mild/moderate and severe disease

Antimicrobial Resistance Case Study 6.